55
Participants
Start Date
November 7, 2014
Primary Completion Date
June 23, 2016
Study Completion Date
June 23, 2016
Cinacalcet HCl
Capsules were opened and either sprinkled onto soft food (≥ 5 mg dose) or suspended into a sucrose syrup (≥ 2.5 mg dose) to create a liquid suspension for administration. Tablets were used for doses of 30 mg and higher in participants who could swallow tablets.
Standard of Care
Standard of care therapy included the use of vitamin D sterols, calcium supplementation, and phosphate binders.
Research Site, Brussels
Research Site, Grafton, Auckland
Research Site, Budapest
Research Site, Leuven
Research Site, Szeged
Research Site, Ghent
Research Site, New York
Research Site, Torino
Research Site, The Bronx
Research Site, Athens
Research Site, Marseille
Research Site, Genova
Research Site, Philadelphia
Research Site, Wilmington
Research Site, Baltimore
Research Site, Greenville
Research Site, Atlanta
Research Site, Hanover
Research Site, Marburg
Research Site, Jackson
Research Site, Louisville
Research Site, Columbus
Research Site, Cleveland
Research Site, Cincinnati
Research Site, Detroit
Research Site, Iowa City
Research Site, Thessaloniki
Research Site, Minneapolis
Research Site, Lille
Research Site, Chicago
Research Site, St Louis
Research Site, St Louis
Research Site, Kansas City
Research Site, Heidelberg
Research Site, Bron
Research Site, Paris
Research Site, Paris
Research Site, Paris
Research Site, Dallas
Research Site, Houston
Research Site, San Antonio
Research Site, Napoli
Research Site, Salt Lake City
Research Site, Los Angeles
Research Site, Moscow
Research Site, Saint Petersburg
Research Site, Samara
Research Site, Boston
Research Site, West Orange
Research Site, Prague
Research Site, Nice
Research Site, Vilinus
Research Site, Krakow
Research Site, Lodz
Research Site, Warsaw
Research Site, Porto
Research Site, Košice
Research Site, Barcelona
Research Site, Espluques de LLobregat
Research Site, Kyiv
Lead Sponsor
Amgen
INDUSTRY